Retinal Dystrophy Treatment Market Size And Share

  • Report Code : TIPRE00015288
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Principales conclusions et analyse des parts de marché du traitement de la dystrophie rétinienne d'ici 2025-2031

Buy Now

Retinal Dystrophy Treatment Market Report Retinal Dystrophy Treatment Market Scope and Analysis Retinal Dystrophy Treatment Market Size and Share

Retinal Dystrophy Treatment Market Report Analysis

Retinal Dystrophy Treatment Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Spark Therapeutics, Inc
  • Novartis AG
  • Biogen
  • HORAMA S.A.
  • MeiraGTx Limited
  • ReNeuron Group plc
  • Retinagenix, LLC
  • Novelion Therapeutics Inc.
  • IVERIC bio

Regional Overview

  • Amérique du Nord
  • Europe
  • Asie-Pacifique
  • Amérique du Sud et centrale
  • Moyen-Orient et Afrique

Market Segmentation

By Type
  • dystrophie périphérique
  • dystrophie centrale
By Thérapie
  • thérapie magnétique
  • thérapie génique
By Traitement
  • médicaments
  • chirurgie
By Voie d'administration
  • orale
  • topique
  • autre